Close

Production & Manufacturing

Beximco Pharma forms JV with Malaysia-based BioCare Manufacturing

Beximco Pharmaceuticals Limited the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the creation of a joint venture with BioCare Manufacturing Sdn Bhd based in Malaysia, as the Company’s first overseas manufacturing collaboration. ...

Baxter in Manesar,Waluj and Alathur

Baxter in Manesar: Baxter’s facility in Manesar, Gurgaon demonstrates excellence in manufacturing for the company’s Medication Delivery and Renal businesses, producing IV and PD solutions. The 21,000 sq.m. facility in Manesar was constructed by Baxter in...

Boehringer Ingelheim BioXcellenceâ„¢ offers reliable world-class biopharmaceuticals contract manufacturing to the pharmaceutical and biotechnology industry.

We offer a complete range of services, from cell line and strain development through process development and large-scale manufacturing to fill and finish. Our extensive portfolio of capabilities and technologies includes the production of antibodies, recombinant proteins, non-antibody scaffolds,...

The road to digital success in pharma

Pharmaceutical companies are running hard to keep pace with changes brought about by digital technology. Mobile communications, the cloud, advanced analytics, and the Internet of Things are among the innovations that are starting to transform the healthcare industry in...

Galena Biopharma Acquires Mills Pharmaceuticals

Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it has acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 (Anagrelide CR), a patented,...

Bayer HealthCare launches oncology treatment Xofigo in UK

Bayer HealthCare has launched Xofigo (radium - 223 dichloride) solution for injection in the UK to treat adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases. The launch follows a positive...

PharmaCell signs deal to produce Dendreon’ Provenge in Europe

Netherlands-based PharmaCell has entered into an agreement with Dendreon to be the contract manufacturing organization (CMO) for the European commercial production of its recently approved cellular immunotherapy product Provenge dispersion for infusion. Provenge is an...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read